Loading
Latest filing published 10 Dec 2025 for Adverum Biotechnologies, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Jr. Mark L. Lupher discloses dealings in Adverum Biotechnologies, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 7 February 2024 and the latest from 9 December 2025.
Every open-market trade on record is a purchase: 1 purchase worth €163k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 10 December 2025 with a transaction in Adverum Biotechnologies, Inc. The last insider purchase was made public on 9 February 2024, 988 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations